Clinical Trial Update: Progesterone Vaginal Pessary for Prevention of Preterm Twin Birth [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating a progesterone vaginal pessary to prevent preterm birth in twin pregnancies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Drugs mentioned

• Progesterone vaginal pessary (progesterone)

Snippet

Sponsor: Assiut University | Conditions: Preterm Birth | Phase 2, Phase 3 | Status: COMPLETED